BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8248084)

  • 1. [Non-enzymatic glycosylation of proteins. Complications of diabetes mellitus, aging and kidney failure].
    Monnier V
    Presse Med; 1993 Oct; 22(30):1413-8. PubMed ID: 8248084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Maillard reaction and crosslinking of corneal collagen in diabetes.
    Sady C; Khosrof S; Nagaraj R
    Biochem Biophys Res Commun; 1995 Sep; 214(3):793-7. PubMed ID: 7575546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
    Verzijl N; DeGroot J; Oldehinkel E; Bank RA; Thorpe SR; Baynes JW; Bayliss MT; Bijlsma JW; Lafeber FP; Tekoppele JM
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):381-7. PubMed ID: 10947951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New biomarkers of Maillard reaction damage to proteins.
    Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
    Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Maillard reaction in the human body. The main discoveries and factors that affect glycation.
    Tessier FJ
    Pathol Biol (Paris); 2010 Jun; 58(3):214-9. PubMed ID: 19896783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal.
    Nagaraj RH; Sarkar P; Mally A; Biemel KM; Lederer MO; Padayatti PS
    Arch Biochem Biophys; 2002 Jun; 402(1):110-9. PubMed ID: 12051689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia.
    Monnier VM; Sell DR; Nagaraj RH; Miyata S; Grandhee S; Odetti P; Ibrahim SA
    Diabetes; 1992 Oct; 41 Suppl 2():36-41. PubMed ID: 1526333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.
    Friedman EA
    Diabetes Care; 1999 Mar; 22 Suppl 2():B65-71. PubMed ID: 10097902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Maillard reaction and its consequences for a living body.
    Sztanke K; Pasternak K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):159-62. PubMed ID: 15323185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proteins modified in the nonenzymatically glycosylation reaction (AGE-proteins)--new markers for diabetes?].
    Zdrojewicz Z; Januszewski A; Kwiatkowska D
    Postepy Hig Med Dosw; 1994; 48(6):689-700. PubMed ID: 7675730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and repair of protein damage by the Maillard reaction in vivo.
    Monnier VM; Sell DR
    Rejuvenation Res; 2006; 9(2):264-73. PubMed ID: 16706654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pentosidine: a new biomarker in diabetes mellitus complications].
    Morales S; García-Salcedo JA; Muñoz-Torres M
    Med Clin (Barc); 2011 Mar; 136(7):298-302. PubMed ID: 20226481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.
    Beisswenger PJ; Moore LL; Brinck-Johnsen T; Curphey TJ
    J Clin Invest; 1993 Jul; 92(1):212-7. PubMed ID: 8325987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical modification of proteins by methylglyoxal.
    Degenhardt TP; Thorpe SR; Baynes JW
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1139-45. PubMed ID: 9846896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms for the formation of glycoxidation products in end-stage renal disease.
    Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM
    Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of Maillard products in the chronic complications of diabetes mellitus. Bioclinical applications].
    Trivin F
    Ann Pharm Fr; 1998; 56(5):193-6. PubMed ID: 9805817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Maillard reaction and food allergies: is there a link?
    Toda M; Heilmann M; Ilchmann A; Vieths S
    Clin Chem Lab Med; 2014 Jan; 52(1):61-7. PubMed ID: 23492561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of type 2 (non-insulin-dependent) diabetes mellitus on pentosidine formation in skin and glomerular basement membrane.
    Sell DR; Carlson EC; Monnier VM
    Diabetologia; 1993 Oct; 36(10):936-41. PubMed ID: 8243873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Native protein glycoxidation and aging.
    Meli M; Frey J; Perier C
    J Nutr Health Aging; 2003; 7(4):263-6. PubMed ID: 12917752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyridoxamine inhibits maillard reactions in diabetic rat lenses.
    Padival S; Nagaraj RH
    Ophthalmic Res; 2006; 38(5):294-302. PubMed ID: 16974131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.